Despite the fact that target antigens and the genetic basis of several autoimmune diseases are now better understood, the initial events leading to a loss of tolerance towards self-components remain unknown. One of the most attractive explanations for autoimmune phenomena involves various infections as possible natural events capable of initiating the process in genetically predisposed individuals. The most accepted explanation of how infection causes autoimmunity is based on the concept of "molecular mimicry" (similarity between the epitopes of an autoantigen and the epitopes in the environmental antigen). Infectious stimuli may also participate in the development of autoimmunity by inducing an increased expression of stress proteins (hsp), chaperones and transplantation antigens, which leads to abnormal processing and presentation of self antigens. Superantigens are considered to be one of the most effective bacterial components to induce inflammatory reactions and to take part in the development and course of autoimmune mechanisms. It has long been known that defects in the host defense mechanism render the individual susceptible to infections caused by certain microorganisms. Impaired exclusion of microbial antigens can lead to chronic immunological activation which can affect the tolerance to self components. Defects in certain components of the immune system are associated with a higher risk of a development of autoimmune disease. The use of animal models for the studies of human diseases with immunological pathogenesis has provided new insights into the influence of immunoregulatory factors and the lymphocyte subsets involved in the development of disease. One of the most striking conclusion arising from work with genetically engineered immunodeficient mouse models is the existence of a high level of redundancy of the components of the immune system. However, when genes encoding molecules involved in T cell immunoregulatory functions are deleted, spontaneous chronic inflammation of the gut mucosa (similar to human inflammatory bowel disease) develops. Surprisingly, when such immunocompromised animals were placed into germfree environment, intestinal inflammation did not develop. Impairment of the mucosal immune response to the normal bacterial flora has been proposed to play a crucial role in the pathogenesis of chronic intestinal inflammation. The use of immunodeficient models colonized with defined microflora for the analysis of immune reactivity will shed light on the mode of action of different immunologically important molecules responsible for the delicate balance between luminal commensals, nonspecific and specific components of the mucosal immune system.

Division of Immunology and Gnotobiology Academy of Sciences of the Czech Republic Prague

Zobrazit více v PubMed

Autoimmunity. 1995;22(2):113-9 PubMed

Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2257-9 PubMed

Biochem Biophys Res Commun. 1995 Apr 17;209(2):597-605 PubMed

Folia Biol (Praha). 1970 Jun;16(3):177-87 PubMed

Immunol Today. 1995 Aug;16(8):399-405 PubMed

Scand J Gastroenterol. 1996 Jun;31(6):551-7 PubMed

Cell. 1993 Oct 22;75(2):263-74 PubMed

Infect Immun. 1995 Oct;63(10):3904-13 PubMed

J Immunol. 1993 Sep 1;151(5):2562-71 PubMed

J Exp Med. 1994 Dec 1;180(6):2359-64 PubMed

Folia Microbiol (Praha). 1979;24(1):58-69 PubMed

Science. 1992 Apr 24;256(5056):483 PubMed

Adv Immunol. 1993;54:99-166 PubMed

Cell. 1993 Oct 22;75(2):253-61 PubMed

Cell. 1993 Oct 22;75(2):203-5 PubMed

Nat Genet. 1995 Jun;10(2):143-50 PubMed

Immunol Today. 1994 Dec;15(12):556-9 PubMed

Folia Biol (Praha). 1980;26(2):81-93 PubMed

Clin Immunol Immunopathol. 1995 Sep;76(3 Pt 2):S172-3 PubMed

Adv Exp Med Biol. 1995;371B:1191-8 PubMed

Nature. 1992 Oct 22;359(6397):693-9 PubMed

Scand J Gastroenterol. 1996 Jan;31(1):61-7 PubMed

Clin Exp Immunol. 1995 Dec;102(3):445-7 PubMed

Clin Immunol Immunopathol. 1995 Feb;74(2):170-6 PubMed

Ann N Y Acad Sci. 1983 Jun 30;409:96-113 PubMed

Int Arch Allergy Immunol. 1992;99(1):16-27 PubMed

Cell. 1993 Oct 22;75(2):274-82 PubMed

J Exp Med. 1997 Jun 16;185(12):2039-41 PubMed

N Engl J Med. 1992 Jul 30;327(5):302-7 PubMed

Scand J Immunol. 1981;13(5):467-72 PubMed

Curr Opin Rheumatol. 1996 Jul;8(4):346-53 PubMed

J Exp Med. 1993 Jul 1;178(1):237-44 PubMed

Diabetes. 1996 Sep;45(9):1173-80 PubMed

Immunity. 1995 Aug;3(2):171-4 PubMed

Cell. 1987 Sep 11;50(6):819-20 PubMed

Clin Immunol Immunopathol. 1995 Jan;74(1):10-22 PubMed

Folia Microbiol (Praha). 1995;40(4):385-91 PubMed

Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2253-6 PubMed

Curr Opin Immunol. 1996 Dec;8(6):831-6 PubMed

Br J Nutr. 1993 Mar;69(2):597-607 PubMed

J Clin Invest. 1996 Aug 15;98(4):945-53 PubMed

Cell. 1995 Mar 10;80(5):695-705 PubMed

Int Immunol. 1993 Nov;5(11):1461-71 PubMed

J Clin Invest. 1996 Aug 15;98(4):1010-20 PubMed

Immunol Lett. 1995 Mar;45(3):179-84 PubMed

Editorial: The gut-pancreas axis in type 1 diabetes - a focus on environmental factors

Increased expression of chemokine receptors CCR1 and CCR3 in nasal polyps: molecular basis for recruitment of the granulocyte infiltrate

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice

Campylobacter sepsis with multiple organ failure in IgG subclass deficiency

The serologic screening for celiac disease in the general population (blood donors) and in some high-risk groups of adults (patients with autoimmune diseases, osteoporosis and infertility) in the Czech republic

The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice